Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In our July edition of CVS Caremark Insights, we explore recent formulary updates aimed at expanding access to these high-demand therapies while improving affordability
an alternative funded GLP-1 receptor agonist As a result of global supply issues with dulaglutide, Pharmac funded an alternative GLP-1 receptor agonist, liraglutide, with Special Authority approval from March, 2023
Understanding how semaglutide makes you feel throughout the injection cycle helps you plan protein intake around your natural appetite patterns
It's a discussion worth having with the provider before starting
Health Canada authorized a second generic semaglutide injection on May 1, 2026, with the department confirming that seven additional generic semaglutide submissions remain under active review
US$ 22.60
US$ 20.95
US$ 23.19
US$ 21.48
